8-KItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements
LABCORP HOLDINGS INC. (LH)

Labcorp to outline strategy and financial outlook at September 10 Investor Day

Filed with the SEC on · Summarized by InvestorsBot

Labcorp will host an Investor Day on September 10, 2026, from 9 a.m. to noon ET, featuring CEO Adam Schechter, CFO Julia Wang and other executives. Management plans to discuss its go-forward strategy, capital deployment priorities and long-term financial outlook, with a live webcast, replay and supporting materials available through the company’s investor relations website.

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from LABCORP HOLDINGS INC.

Labcorp executives to speak at Morgan Stanley healthcare conference

8-K · August 28, 2026

Labcorp’s Megan Bailey to Resign; Brian Caveney to Lead Biopharma Laboratory Services

8-K · August 14, 2026

Labcorp CEO Adam Schechter sells $1.5M in stock

Form 4 · Insider Trade · August 12, 2026

Labcorp Raises 2026 Guidance After Strong Second-Quarter Results

8-K · July 30, 2026

Labcorp ($LH) 8‑K: Term Loan Credit Agreement dated Mar 20, 2026 among Labcorp Holdings and lenders;…

8-K · March 20, 2026

LABCORP ($LH) 8-K filed 2026-03-20 — Item 2.03 states it incorporates Item 1.01 by reference re: creation…

8-K · March 20, 2026